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Abstract 
Background: Pillboxes are widely available, but optimizing pillboxes in self-management 
interventions requires an understanding of important intervention components. 
Purpose: To review components of intervention design, interventionist training, delivery, 
receipt, enactment and targeted behaviors in adherence studies. 
Method: Five multi-disciplinary databases were searched to find reports of controlled 
trials testing pillboxes and medication adherence interventions in adults managing 
medications. Details of treatment fidelity:  Design, Training, Delivery, Receipt, and 
Enactment were abstracted.  
Discussion: A total of 38 articles reporting 40 studies were included. Treatment fidelity 
descriptions were often lacking, especially with regard to reporting receipt and 
enactment. This review demonstrates there are significant limitations in existing 
literature reporting on the use of pillboxes in medication adherence interventions.  
Conclusions: These findings serve as a call to action to explicitly state pillbox 
intervention details. The lack of details provides challenges in translating which 
components of pillboxes work in influencing medication adherence behaviors and 
outcomes. 
Key words: Medication adherence; treatment fidelity; Pillboxes; behavioral interventions 
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Review Chronic conditions affect 117 million adults across the United States 
(US) (Ward, Schiller, & Goodman, 2014), with the majority of these individuals taking at 
least one medication. Consistent medication adherence, defined as taking medication 
as prescribed, is a key treatment and important for managing disease progression 
(Jafar et al., 2003; Ruggenenti et al., 1998). Poor medication adherence can lead to 
disease progression, increased morbidity, and mortality. Between 20% and 50% of 
people are nonadherent to the prescribed medication regimen, that is, they do not have 
daily persistence in taking medications as prescribed, and this nonadherence may be 
responsible for up to 10% of all hospitalizations (Viswanathan et al., 2012). Good 
medication self-management includes knowing how to take medications as well as 
possessing the skills and demonstrating the behaviors to act on that knowledge (Bailey, 
Oramasionwu, & Wolf, 2013). Sustained medication adherence includes following 
prescribed medication regimens, adhering to dosing instructions, timely reporting of side 
effects, and developing habits to remember to take medications (Vrijens et al., 2012). 
Medication adherence thus requires remembering ‘how’ to take medication 
(retrospective memory) and remembering ‘when’ to take medications (prospective 
memory); both are components people may struggle with in managing medications. 
Several systematic reviews have found evidence that pillboxes are effective 
interventions to support adherence to prescribed medication regimens (Boeni, 
Spinatsch, Suter, Hersberger, & Arnet, 2014; Conn et al., 2014; Zedler, Kakad, Colilla, 
Murrelle, & Shah, 2011). Pillboxes are containers that store scheduled doses of 
medications, and they are ubiquitous, sold nearly everywhere, and are inexpensive 
options to encourage medication-taking behaviors. They come in many different sizes, 
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shapes, and designs, ranging from simple single pillboxes used for one day to multiple 
boxes for multiple pills across multiple days.  
Despite recognition that pillboxes may be effective in supporting medication 
adherence (Boeni et al., 2014; Conn et al., 2014), translating new knowledge from 
intervention studies into practice requires an understanding of salient intervention 
components. Such components consist of the “active ingredients” of the intervention 
designed to change behavior, that is, how the intervention was designed, delivered, and 
received and for whom it was successful. Intervention fidelity refers to methodological 
strategies that enhance confidence, reliability, and validity relative to intervention 
outcomes. Borrelli et al. (2005) outlined strategies to enhance intervention fidelity in 
behavioral interventions, specifically fidelity in the design, training, delivery, receipt, and 
enactment relative to these interventions. By understanding the targeted behaviors and 
behavioral change strategies linked with pillbox use, researchers and practitioners can 
increase their ability to judge the effectiveness of pillboxes and better integrate pillboxes 
into behavioral interventions.   
We undertook this review to understand the extent to which pillboxes have been 
integrated into intervention design, training of providers, delivery, receipt, and 
enactment and for which targeted behaviors pillboxes were used. The purpose of this 
review was to identify these intervention fidelity components in published primary 
intervention studies.  
Methods 
Search Strategies 
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We conducted a review with the assistance of an experienced reference librarian. 
Five multi-disciplinary databases (CINAHL, PubMed, Family & Society Studies 
Worldwide, PsycINFO, and SocINDEX) were searched to find literature related to 
medication adherence and the use of pillboxes. The final search terms used included all 
combinations of pill, prescription, medication, or drug AND box, container, case, 
organizer, or reminder, combined with the additional phrases, "medication compliance" 
or "medication adherence."  Limits included scholarly, peer-reviewed journals, and 
journal articles. After removing non-English language abstracts, duplicate articles 
across databases, and non-academic periodicals, 141 results were returned from a 
combination of database searching and hand-searching references. See the flow 
diagram in Figure 1.  
Figure 1. Study Flow Diagram 
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Inclusion Criteria 
We included reports of controlled clinical intervention trials targeting increasing 
medication adherence in adults managing their own medications. We included both 
studies in which pillboxes were recommended or provided. Pillboxes were defined as 
containers with compartments designated for scheduled medications to be taken at a 
particular time or during a particular day.  
Any studies conducted in patient populations in which medications could be 
deemed elective or temporary (e.g., smoking cessation, contraceptives, sexual 
dysfunction) were excluded. Studies focused on mental illness or psychiatric conditions 
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(e.g., major clinical depression, bipolar disorder) and populations with coexisting 
substance abuse were excluded from this review because of potential differences in 
factors influencing nonadherence such as the risk for substance abuse and beliefs 
about medications (Higashi et al., 2013; Jonsdottir et al., 2013). Trials using electronic 
adherence measuring devices (e.g., the Medication Event Monitoring System) were not 
included when the sole purpose of the device was for measurement rather than 
behavior change.   
Data Coding and Quality Evaluation 
Two independent reviewers selected articles for review. Once consensus was 
reached through discussion about which data to collect based on the study purpose and 
research questions, data were then extracted. Data included the author, publication 
year, study design, duration of the intervention and study follow-up, participant 
description (e.g., clinical conditions and number of medications), and whether the study 
was designed to treat and/or prevent nonadherence.  A coding scheme was developed 
based on guidelines and best practices in intervention fidelity (Borrelli et al., 2005). Five 
categories of treatment fidelity have been identified to enhance the reliability and validity 
of findings from behavioral interventions (Borrelli et al., 2005): Design, Training, 
Delivery, Receipt, and Enactment. We define below each of these fidelity components in 
the context of pillbox components of interventions. 
Design. Treatment design refers to the basic design of a trial as well as other 
components related to the content and dose of the intervention and control groups. For 
this review, important design components included descriptions about the treatment of 
the control and intervention groups and the components of the intervention. We 
PILLBOX INTERVENTION FIDELITY 
7 
examined studies for inclusion criteria suggesting that patients were included in the 
study because of prior problems with nonadherence. These studies were classified as 
being “designed to treat nonadherence.” If studies were designed to promote adherence 
to medications and patients were not screened for previous history of nonadherence, 
they were classified as “designed to prevent nonadherence.” We extracted information 
to determine if the study was designed for all intervention group participants to receive 
the pillbox or if it was designed for all to receive a recommendation to use a pillbox. 
Studies in which pillboxes were recommended were included if criteria were established 
for when participants received a recommendation to use a pillbox. We specifically 
looked for explanations of when the pillbox was provided, under what circumstances 
pillboxes were recommended, and formal assessments developed based on these 
criteria. Treatment dose was evaluated based on number of contacts in which the 
pillbox was discussed, if applicable to the study design. Finally, we extracted whether 
interventionist qualifications were mentioned. 
Training. Interventionist training and credentials were extracted when reported. 
This included assessing if or how reports described how providers were trained to 
deliver the pillbox component of the intervention, including training the interventionist on 
how to use the pillbox, when to use the pillbox, and when to recommend the pillbox. 
Descriptions were examined to determine if interventionist skill was measured following 
any training and if the interventionist was monitored across the duration of the study to 
maintain fidelity and consistency in intervention delivery.  
Delivery. We looked for content indicating that a treatment manual or checklist 
was used in order to ensure the pillbox was delivered or recommended as intended.  
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We also examined whether the delivery of the pillbox intervention component mentioned 
how participants were taught how to use the pillbox.  
Receipt. To determine treatment receipt, we extracted information suggesting 
that all participants who should have received a pillbox did receive the pillbox or, in the 
case of pillbox recommendations, that records were reported indicating how many 
people received a recommendation. We examined both descriptions and actual study 
findings reporting the number of participants receiving the pillbox or the 
recommendation. In addition to receiving the pillbox or a recommendation, we extracted 
whether study descriptions mentioned assessment of patients’ skill acquisition specific 
to the pillbox. This included ensuring that the participant could use the pillbox as 
designed in the study.  
Enactment. For pillbox enactment, we evaluated reports for descriptions of 
whether patients used the pillbox. If user feedback from participants was included, we 
noted this as well. Any descriptions that suggested the study assessed participants’ use 
of the pillbox were reviewed. This included descriptions about the utility of, usability of, 
and/or satisfaction with the pillbox. We also looked at whether studies had assessed if 
participants actually used the pillbox, including reporting the number of participants who 
had used the pillbox and/or if a method was put in place to ensure the pillbox was used. 
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Results 
A total of 38 articles reporting 40 studies met our inclusion criteria for this review. 
Study characteristics are described in Table 1. 
Table 1: Study Characteristics 
Author Year Country Sample 
Study 
Design Intervention 
Ascione 1984 USA 
Cardiovascular/ 
Geriatrics   
(N = 158) 
RCT 
Multicomponent to improve 
attitudes, knowledge, & 
compliance behavior 
Bosworth 2008 USA 
Hypertension 
(N = 636) 
RCT 
Multicomponent tailored 
behavioral intervention 
Burrelle 1987 USA 
Hypertension 
(N = 16) 
RCT 
Multicomponent interdisciplinary 
compliance service 
Calvert 2012 USA 
CAD 
(N = 143) 
RCT 
Multicomponent patient-focused 
counseling intervention 
Crome 1980 UK 
Geriatrics 
Study 2: (N=14) 
Study 3: (N=26) 
Study 2 - 
NRCT 
Study 3 - 
Cross-
over 
RCT 
Medication packaging 
intervention 
Fairley 2003 Australia 
HIV 
(N = 43) 
RCT with 
"Stepped
-Wedge"
design*
Multicomponent adherence 
package 
Farsaei 2011 Iran 
Diabetes 
(N = 172) 
RCT 
Multicomponent educational 
intervention 
Goldstein 2014 USA 
Cardiovascular 
(HF) (N = 60) 
2 x 2, 
open-
label, 
RCT 
Memory aid to improve 
medication adherence 
Goujard 2003 France HIV (N = 367) RCT 
Multicomponent educational 
intervention 
Huang 2000 USA 
TRACE: (N = 
184) 
VITAL: (N = 297) 
TRACE 
trial: 
Placebo-
controlle
d, 
double-
masked, 
2x2 
Multicomponent pill organizer & 
vitamin supplementation 
intervention 
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factorial 
design 
VITAL 
trial: 
Placebo-
controlle
d, 
double-
masked 
pilot trial 
design 
Kalichman 2011 USA 
HIV/AIDS 
(N = 40) 
RCT 
Behavioral self-management 
intervention 
Kennedy 1990 USA Elderly (N = 65) RCT 
Multicomponent self-care 
education intervention 
Kripalani 2012 USA 
Cardiac Diseases 
(N = 851) 
RCT 
Multicomponent pharmacist 
intervention for low literacy in 
cardiovascular disease 
Laramee 2003 USA 
CHF 
(N=287) 
RCT 
Multicomponent intervention with 
discharge planning, education, 
follow-up, and promotion of 
optimal medication management 
Lee 1999 USA 
Gastrointestinal 
Disorders  
(N = 125) 
RCT 
Multicomponent enhanced 
compliance program 
Levensky 2006 USA 
HIV 
(N  = 54) 
RCT 
Multicomponent adherence 
counseling and education 
intervention 
MacDonald 1997 UK 
Chronic Disease 
(N = 165) 
RCT 
Multicomponent counseling 
interventions 
Macintosh 2007 Canada 
Cancer 
(N = 25) 
Prospect
ive, 
cross-
over 
design 
Medication packaging 
intervention 
Maier 2006 Austria 
Type 2 Diabetes 
(N = 2081) 
RCT 
Pocket-size tablet dispensing 
device intervention 
McPherson-
Baker 
2000 USA 
HIV 
(N = 42) 
NRCT 
Multicomponent behavioral 
intervention 
Miaskowski 2004 USA 
Cancer patients 
experiencing pain 
(N = 174) 
RCT 
Multicomponent PRO-SELF Pain 
Control Program 
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Moshkovska 2011 UK 
Gastrointestinal 
Disease  
(N = 84) 
RCT* 
Multicomponent tailored patient 
preference intervention 
Murray 1993 USA 
Geriatrics 
(N = 31) 
RCT 
Medication packaging 
intervention 
Nochowitz 2009 USA 
Warfarin therapy 
(N = 13) 
 NRCT 
Prospect
ive 
cohort 
study 
Adherence aid intervention 
Park 1992 USA 
Chronic Disease 
(N = 61) 
RCT Cognitive support intervention 
Peterson 1984 Australia Epilepsy (N = 53) RCT 
Multicomponent compliance-
improving strategies intervention 
Porter 2014 USA 
Hypertension 
(N = 60) 
NRCT 
Prospect
ive 
Pre/Post 
Pill box clinic 
Rehder 1980 USA 
Hypertension 
(N = 100) 
RCT 
Multicomponent counseling & 
special prescription container 
interventions 
Suárez-
Varela 
2009 Spain 
Chronic Disease 
(N = 220) 
RCT Pillbox 
Schmidt 2008 Germany 
Heart Failure 
(N = 62) 
NRCT 
Pre/Post 
Tele-monitoring with electronic 
box 
Suppapitiporn 2005 Thailand 
Diabetes 
(N = 360) 
RCT 
Multicomponent drug counseling 
intervention 
Sweeny 1989 UK 
Chronic Disease 
(N = 103) 
NRCT Counseling intervention 
Taylor 2003 USA 
Chronic Disease 
(N = 69) 
RCT 
Multicomponent pharmaceutical 
care (educational) intervention 
Traiger 1997 USA 
Transplant 
(N = 41) 
NRCT 
Pilot 
study 
Multicomponent self-medication 
administration program 
Tsuyuki 2004 Canada 
Heart Failure 
(N = 276) 
RCT 
Multicomponent, multicenter 
disease management program 
Wang 2010 China 
HIV/AIDS 
(N = 116) 
RCT 
Multicomponent nurse-delivered 
home visits & phone call 
intervention 
Winland-
Brown 
2000 USA 
Chronic disease 
(N = 61) 
RCT 
Medication management 
approaches 
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Several different chronic conditions were studied including six conducted in 
HIV/AIDS, five in hypertension/uncontrolled blood pressure, two in gastrointestinal 
disorders, eight in cardiovascular-related conditions (coronary artery disease, cardiac 
disease, congestive heart failure, warfarin therapy), six in chronic conditions, three in 
diabetes, two in cancer, one each in transplant and epilepsy, two in vitamin 
supplementation, and four studies focused specifically on the older adult patient 
population. The subject sample sizes ranged from 13 to 2081 across studies. All, but 
one article, were written in English, and a trained medical interpreter provided 
translation service for the non-English article, which was written in Spanish. The five 
components of intervention fidelity assessed in this review are detailed in Table 2.  
Table 2: Percentage of Articles (N=38) Reporting Use of Pillbox Intervention Fidelity 
Strategies 
Treatment Fidelity Strategies % (n) reporting* 
Pillbox Intervention Design 
Designed to treat nonadherence 29% (11) 
Designed for all intervention group participants to receive 
the pillbox  
71% (24/34a) 
Criteria established for when to recommend a pillbox to 
participants 
20% (2/10b); 5 NR 
Provided pillbox description in studies that provided 
pillboxes (n=34) 
55% (21);15 NR 
Provided a pillbox to participants 89% (34); 1 NR 
Interventionist qualifications 79% (30); 8 NR 
Interventionist Training 
Interventionist training specific to the pillbox component 
(how to use, when to use, etc.),  
5%(2); 35 NR;1 NA 
Zillich 2005 USA 
Uncontrolled BP 
(N = 125) 
RCT 
Multicomponent pharmacist -
based home blood pressure 
monitoring program 
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Measured interventionist skill following training 6%(2); 34 NR; 2 NA 
Mention of interventionist monitoring across study duration 7.9% (3); 35 NR 
Delivery of Pillbox Intervention 
Included method to ensure the pillbox was delivered or 
recommended as intended (treatment manual, checklist) 
7.9% (3); 35 NR 
Mentioned participants were instructed/taught how to use 
the pillbox;  
34% (19); 18 NR;1 NA 
Receipt of Pillbox Intervention 
Reviewers had to assume the number of participants who 
received a pillbox based on study design 
21% (8); 8 NR; 1 NA 
55% (21) 
Assessed patients’ skill acquisition specific to the pillbox  21% (8); 29 NR; 1 NA; 
Enactment of Pillbox 
Assessed utility, usability, and/or satisfaction 32% (12); 26 NR 
Reported number who used pillbox/method to ensure 
pillbox was used;  
16% (6) 
Note: NR - Not reported; NA - Not applicable based on study design; 
ain studies that provided pillboxes 
bin studies that recommended pillboxes 
Intervention Design. Pillbox interventions were largely designed to prevent 
nonadherence. Eleven studies (Burrelle, 1986; Fairley et al., 2003; Kalichman et al., 
2011; Laramee, Levinsky, Sargent, Ross, & Callas, 2003; Levensky, 2006; McPherson-
Baker et al., 2000; Morales, 2009; Nochowitz, Shapiro, Nutescu, & Cavallari, 2009; 
Schmidt, Sheikzadeh, Beil, Patten, & Stettin, 2008; Taylor, Byrd, & Krueger, 2003; 
Winland-Brown & Valiante, 2000) were designed to treat nonadherence and used 
nonadherence as screening or inclusion criteria for participation in the study. Self-report 
was most often used to measure nonadherence. The 4-item Morisky Medication 
Adherence Scale (MMAS-4) questionnaire was used in two studies (Burrelle, 1986; 
Fairley et al., 2003), and one study used a version of the MMAS(Morales, 2009) 
whereas two studies assessed self-report of missed doses over the preceding month 
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(Fairley et al., 2003; Kalichman et al., 2011). Laramee et al.(2003) included both those 
at risk for nonadherence and those with a past history of such, although how this 
assessment was made was not explained. McPherson-Baker et al. and Taylor et al. 
used medication-refill patterns as indicators of nonadherence. Two studies used the 
medical record to screen for a documented history of nonadherence(Taylor et al., 2003; 
Winland-Brown & Valiante, 2000). Winland-Brown et al. and McPherson-Baker et al. 
included hospitalization that could be related to medication mismanagement as an 
indicator of nonadherence.  
 Thirty-four studies provided pillboxes to participants (Ascione & Shimp, 1984; 
Burrelle, 1986; Calvert et al., 2012; Crome, Akehurst, & Keet, 1980; Fairley et al., 2003; 
Farsaei, Sabzghabaee, Zargarzadeh, & Amini, 2011; Goldstein et al., 2014; Goujard et 
al., 2003; Huang, Maguire, Miller, & Appel, 2000; Kennedy, 1990; Kripalani et al., 2012; 
Laramee et al., 2003; Lee et al., 1999; Macdonald, MacDonald, & Phoenix, 1977; 
Macintosh, Pond, Pond, Leung, & Siu, 2007; Maier, Mustapic, Schuster, Luger, & Eher, 
2006; McPherson-Baker et al., 2000; Morales, 2009; Moshkovska et al., 2011; Murray, 
Birt, Manatunga, & Darnell, 1993; Nochowitz et al., 2009; Park, Morrell, Frieske, & 
Kincaid, 1992; Peterson, McLean, & Millingen, 1984; Porter, Taylor, Yabut, & Al-Achi, 
2014; Rehder, McCoy, Blackwell, Whitehead, & Robinson, 1980; Schmidt et al., 2008; 
Suppapitiporn, Chindavijak, & Onsanit, 2005; Sweeney, Dixon, & Sutcliffe, 1989; Traiger 
& Bui, 1997; Tsuyuki et al., 2004; Wang et al., 2010; Winland-Brown & Valiante, 2000). 
Crome et al.(1980) and Huang et al.(2000) each reported on two pillbox studies), and 
five studies recommended pillboxes (Bosworth et al., 2008; Kalichman et al., 2011; 
Levensky, 2006; Taylor et al., 2003; Zillich, Sutherland, Kumbera, & Carter, 2005). 
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Kalichman et al.(2011) recommended a pillbox when participants found it difficult to 
manage medications or if they kept pillboxes in multiple places, whereas Bosworth et 
al.(2008) recommended a pillbox when participants reported difficulty remembering to 
take medications. Sweeny et al.(1989) provided a pillbox to participants if the 
pharmacist believed the participant could benefit from it, but no criteria about how this 
judgment was made were reported. One article did not include details about whether the 
pillbox was provided or recommended as part of the study (Miaskowski et al., 2004). Of 
those studies in which a pillbox was provided, four(Macintosh et al., 2007; Murray et al., 
1993; Rehder et al., 1980; Winland-Brown & Valiante, 2000) prefilled the pillboxes with 
the participants’ medications and 11 required participants to fill their own pillboxes 
(Ascione & Shimp, 1984; Burrelle, 1986; Huang et al., 2000; Laramee et al., 2003; Lee 
et al., 1999; Maier et al., 2006; McPherson-Baker et al., 2000; Park et al., 1992; Porter 
et al., 2014; Traiger & Bui, 1997; Wang et al., 2010). Nochowitz et al. (2009) filled 
pillboxes for participants if they brought their medications to the study appointment; 
otherwise, participants were required to fill their own. Of the 34 studies that provided 
pillboxes, 29 studies were designed for intervention group participants to automatically 
receive the pillbox as part of the intervention; these were reported in 27 articles 
(Ascione & Shimp, 1984; Burrelle, 1986; Calvert et al., 2012; Crome et al., 1980; 
Farsaei et al., 2011; Goldstein et al., 2014; Goujard et al., 2003; Huang et al., 2000; 
Kripalani et al., 2012; Lee et al., 1999; Macdonald et al., 1977; Macintosh et al., 2007; 
Maier et al., 2006; McPherson-Baker et al., 2000; Morales, 2009; Murray et al., 1993; 
Nochowitz et al., 2009; Park et al., 1992; Peterson et al., 1984; Porter et al., 2014; 
Rehder et al., 1980; Schmidt et al., 2008; Suppapitiporn et al., 2005; Traiger & Bui, 
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1997; Tsuyuki et al., 2004; Wang et al., 2010; Winland-Brown & Valiante, 2000). In the 
other five studies, participants may have received a recommendation for or offered the 
use of a pillbox, and if they accepted the offer, they were then provided with a specific 
pillbox to use (Fairley et al., 2003; Kennedy, 1990; Laramee et al., 2003; Moshkovska et 
al., 2011; Sweeney et al., 1989).   
Eight of the above studies used either a subgroup that was provided with a 
pillbox as part of the intervention or had an additional treatment arm as part of the study 
(Ascione & Shimp, 1984; Goldstein et al., 2014; Macdonald et al., 1977; Murray et al., 
1993; Park et al., 1992; Rehder et al., 1980; Suppapitiporn et al., 2005; Winland-Brown 
& Valiante, 2000). Most studies (n = 31) included a usual care control group as part of 
the study design. In two studies included in this review there were reports of potential 
contamination, with 19 people in one study from the control group attending the 
intervention education sessions where pillboxes were distributed (Goujard et al., 2003), 
and in another study, 39% (n=7) of the attention control group reported using pillboxes 
(Kalichman et al., 2011). Fairley et al.(2003) reported that 42% (18/43) of study 
participants reported already using pillboxes at enrollment. Other studies in this review 
did not report if they evaluated whether the control group participants used pillboxes. 
With regard to treatment dose, there were some reports of at least one contact session 
that specifically covered pillbox use (Farsaei et al., 2011; Goujard et al., 2003; Lee et 
al., 1999; Miaskowski et al., 2004; Park et al., 1992; Porter et al., 2014; Rehder et al., 
1980; Wang et al., 2010).  
Interventionist Qualifications and Training. Of those studies reporting the 
qualifications of the interventionist, most used exclusively nurses (Bosworth et al., 2008; 
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Crome et al., 1980; Fairley et al., 2003; Kennedy, 1990; Laramee et al., 2003; 
Miaskowski et al., 2004; Morales, 2009; Traiger & Bui, 1997; Wang et al., 2010) (n = 9) 
or exclusively pharmacists(Ascione & Shimp, 1984; Calvert et al., 2012; Farsaei et al., 
2011; Kripalani et al., 2012; Lee et al., 1999; Macdonald et al., 1977; McPherson-Baker 
et al., 2000; Murray et al., 1993; Porter et al., 2014; Rehder et al., 1980; Suppapitiporn 
et al., 2005; Sweeney et al., 1989; Taylor et al., 2003; Tsuyuki et al., 2004; Zillich et al., 
2005) (n = 15), and the remaining few (n = 6) used a variety of and/or different 
combinations of personnel (e.g., nurses, social workers, nutritionists, physicians) 
(Burrelle, 1986; Goujard et al., 2003; Kalichman et al., 2011; Levensky, 2006; 
Moshkovska et al., 2011; Schmidt et al., 2008). Nochowicz (2009) did not specifically 
report interventionist qualifications, but the intervention was carried out in a pharmacist-
run clinic and all investigators were pharmacists. Only two articles reported whether 
these interveners underwent training in delivering the intervention specific to the pillbox 
component (Bosworth et al., 2008; Traiger & Bui, 1997).  
Delivery of the Intervention. Ten articles reported that some type of content about 
using the pillbox was included in the intervention, although this content varied widely 
(Kalichman et al., 2011; Lee et al., 1999; Morales, 2009; Nochowitz et al., 2009; Park et 
al., 1992; Peterson et al., 1984; Porter et al., 2014; Rehder et al., 1980; Schmidt et al., 
2008; Taylor et al., 2003). For example, Kalichman et al.(2011) used pillboxes along 
with self-regulation counseling in which pillboxes were discussed with participants to 
support medication management skills such as planning and organizing of medications 
in routines, but no specific details were provided. Lee et al.(1999) used a pharmacist to 
teach participants to fill a pocket-sized pillbox, but no details were provided. Porter et al. 
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(2014) also used a pharmacist, and when patients and caregivers did not fill the pillbox 
correctly the pharmacist then read the labels on the bottles while observing and, if 
necessary, correcting the participants filling the pillboxes. Two studies mentioned that 
participants were taught how to use the pillbox, including how to fill the box (Park et al., 
1992; Porter et al., 2014). One study used a home nurse to assist with the pillbox filling 
if the patient was not capable of it (Sweeney et al., 1989). Schmidt et al. (2008) used a 
pillbox with tele-monitoring capabilities and an alarm; the instructions on how to use the 
pillbox were related to how to silence the alarm by opening the box and how to ensure 
the data were electronically recorded. On the other hand, Maier and colleagues (2006) 
reported they purposely did not include content about how to use the pillbox. 
Receipt of the Intervention. It was difficult to extract the number of people receiving 
the intervention. Eight articles specifically mentioned the number of participants 
receiving the pillbox; however, most of the receipt classification was assumed based on 
study design (Fairley et al., 2003; Kalichman et al., 2011; Levensky, 2006; Macdonald 
et al., 1977; Maier et al., 2006; Moshkovska et al., 2011; Nochowitz et al., 2009; Park et 
al., 1992). As an example, in Levensky and colleagues’ study (2006), 50% of 
intervention participants (n = 12) were given a recommendation to use pillboxes, and 
this recommendation was made at three time points consistent with the study design. 
However, it is unclear if these were the same 12 people or a combination of different 
people in the intervention group. There was also variation in the reporting of 
assessment of patient skill in using the pillbox. For example, Crome et al. (1980) 
reported the time it took for patients to acquire skill, whereas Sweeney et al. (1989) 
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mentioned patients’ expression of concern about filling pillboxes. Two studies permitted 
participants to self-select pillbox use (Fairley et al., 2003; Moshkovska et al., 2011).  
Enactment of the Intervention. Very few studies evaluated if participants actually used 
the pillbox. In particular, only six articles specifically reported enactment or used a 
design that required the pillbox to be used because of the nature of the intervention 
(Burrelle, 1986; Crome et al., 1980; Goldstein et al., 2014; Levensky, 2006; Macdonald 
et al., 1977; Macintosh et al., 2007). Levensky (2006), Burelle et al.(1986) and 
MacIntosh et al. (2007) counted the number of pills remaining in the pillbox to evaluate 
medication adherence and therefore it is assumed the pillbox was used. Nochowitz et 
al. (2009) also performed a pill count when participants brought their pillboxes to the 
clinic, but not all participants brought their pillboxes to the clinics and therefore it is 
unclear how many participants used the pillbox. Crome et al.(1980) used a specific 
pillbox (Dosette) and participants had to use the box appropriately in order to progress 
in the study; these participant numbers were provided by the authors. Goldstein et al. 
(2014) utilized an electronic sensing pillbox that recorded opening and closing of the 
device and therefore was able to demonstrate use. MacDonald reported pillbox use and 
specifically that 40% (n=6) of users had stopped using the pillbox over the 12 weeks of 
the intervention.  
Approximately one third of the studies assessed patients’ experiences in using 
the pillbox. Pillbox use was mentioned as being helpful in some studies and in others 
use dwindled over time. For example, Levensky et al.(2006) reported pillbox receipt and 
use for three time points and whether the pillbox recommendations were fully or partially 
implemented. At the first time point, 100% of participants who had been given 
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recommendations for pillboxes reported they fully used them, but this number declined 
over the 6-week time period and had further declined by the last study time point at 20 
months out, with approximately half fully implementing the intervention and half partially 
implementing the pillbox intervention. In one study,(Lee et al., 1999), that included a 
multicomponent intervention consisting of pharmacist-delivered education, a calendar, 
and pillbox, participants found the pillbox component to be the most helpful.  
Discussion 
The present review sought to describe the extent to which intervention fidelity 
components have been integrated into interventions using pillboxes. Of the 40 studies 
reported in the 38 articles included in our review, there were varying degrees of detail 
reported about pillbox intervention fidelity. These differences in key intervention details 
make it difficult to know if and when pillboxes are an effective component of medication 
adherence-related interventions, limit replication of studies, and limit translation of study 
findings into practice.  
Intervention fidelity is critical to interpreting studying findings with confidence and 
translating these into practice. There was significant disparity and heterogeneity found 
in intervention descriptions with respect to intervention fidelity. This leads to challenges 
in synthesizing study findings in any meaningful way for translation into practice. For 
example, less than 20% of the articles reported a method to ensure that participants 
actually used the pillbox component of the intervention. Therefore, it is difficult to 
determine whether the pillbox played an integral role in influencing medication 
adherence behaviors and outcomes. Moreover, few of the articles reported the number 
of participants who received a pillbox and how many were still using the pillbox at the 
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end of the study. We suggest that reporting the numbers of participants receiving 
treatment and enacting treatment is as important as reporting attrition or performing an 
intention-to-treat analysis.  Without reporting receipt and enactment numbers, 
conclusions about the effectiveness of using pillboxes are limited.  
In articles that described the pillbox as part of the intervention, we assumed that 
all participants did in fact receive the pillbox, which may not be a valid assumption.  
Although this might be inferred from the number of people in the intervention group, it 
also relies on the study being designed to ensure that the study protocol was in fact 
carried out the way it was planned, and these details were often lacking. Therefore, it 
cannot be readily assumed that those who should have received the pillbox did so, 
especially given the lack of outcome measures that accounted for the sample size 
receiving the pillbox. This highlights the need for authors to more clearly articulate 
intervention fidelity components so that conclusions can be based on actual findings 
and not assumptions. 
Articles included in our review specifically identified use of compartmentalized 
containers or identified the brand name of the pillbox, which allowed us to confirm the 
study met inclusion criteria. However, this relied on authors including these details in 
their publication, details critical to advancing the science. Based on our inclusion 
criteria, articles needed to report use of a multi-compartment storage container or 
provide enough details to confirm this requirement (brand name, picture, etc.) and 
blister or foil packaging were not included. Articles included in our review may differ 
from articles included in past reviews (Conn et al., 2014) based on our inclusion criteria. 
One important factor that may explain this difference is that the researchers in these 
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other articles contacted authors to gain details on studies when specific details were not 
included, and we did not use this approach as our focus was on the extent to which 
these descriptions were reported in the literature. We only focused our review on 
descriptions reported in the literature because these descriptions contain details that 
affect both interpretation of study findings and translation of the intervention into 
practice (Bellg et al., 2004; Borrelli, 2011).  
Differences in how pillboxes were used to support medication taking were noted 
across studies. First, some interventions were designed to treat nonadherence whereas 
some were designed to prevent nonadherence. This difference in study design may be 
important in deciding which patient populations may most benefit from use of pillboxes 
or pillboxes may be effective for everyone, but that is unclear given the lack of detail 
related to treatment fidelity. Second, no article reported if participants’ past use of 
pillboxes was assessed. The literature suggests that as many as 50-77%47,48 of people 
report using pillboxes on their own. In light of these statistics, one potential limitation of 
using usual care group comparisons is that many of those in the usual care groups are 
likely to be using pillboxes on their own, therefore, highlighting the need to assess for 
current pillbox use in comparison groups. 
It is unclear how the pillbox was used as a strategy to support medication 
management and adherence. Approximately half of the articles in our review stated that 
pillboxes were used as memory aids. For example, Park et al.(Park et al., 1992) found 
that in the older adult population errors of omission were frequent, but use of a pillbox 
and reminder calendar may help reduce cognitive effort and support prospective 
memory,37 that is, remembering when to take medication. However, it is unclear which 
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design features of a pillbox actually support prospective memory. For example, an 
alarm or placement in sight of a pillbox might cue a person to take the medication, 
whereas an empty pillbox container might cue a person that the medication has been 
taken (retrospective memory). These memory-related components that support 
medication taking operate in different ways, that is, the active ingredients of changing 
behaviors rely upon different understandings of the specific behaviors that require 
changing in order to achieve medication adherence. Participants reported that pillboxes 
were helpful; however, the salient features of the pillboxes and the actual medication-
taking behaviors that were supported by the use of a pillbox are unknown. 
Limitations 
The findings of this review should be interpreted in light of some limitations. 
Some of these studies were published prior to systematic guidelines for reporting 
randomized clinical trials such as the CONSORT guidelines(Begg et al., 1996) and the 
publication about components of treatment fidelity.(Borrelli et al., 2005) For this reason, 
these details may have been lacking in some articles. We also marked treatment fidelity 
characteristics as “not reported” in many cases rather than contacting the study 
investigators to obtain these details. In order to facilitate scientific advancement and 
prevent readers from making assumptions, we believe it is imperative for authors to 
publish details about their interventions such as the specific targeted behaviors that 
pillboxes serve to mediate and the intervention fidelity components. We cannot rely on 
systematic review investigators to track down and report these details.  
Implications for Research 
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Future research should seek to identify the behaviors that are supported by use 
of pillboxes, which pillbox design features support those behaviors, and which patient 
attributes might best be suited to specific behavior change techniques using a pillbox. 
This information would be helpful to establish clear indications for when a pillbox may 
be effective and for whom. In order to conduct this research, medication adherence 
researchers will need valid and reliable measures of medication adherence applicable 
to those who use pillboxes. We propose that pillbox intervention fidelity components be 
incorporated into well-designed trials and that fidelity components be reported in future 
publications to facilitate translation into practice. 
Conclusions 
This review demonstrates there are significant limitations in the existing literature 
reporting on the use of pillboxes in medication adherence interventions. The 
effectiveness of pillboxes cannot be fully determined if intervention components such as 
intervention fidelity are not clearly described within studies. Failure of authors to do this 
limits the advancement of science. Based on the studies reviewed herein, there is little 
evidence about the effectiveness of pillboxes as an intervention to support medication 
management and medication adherence. In order to determine the effects of a 
treatment on an outcome, methodological strengths including treatment fidelity must be 
considered. Based on the current evidence, few studies have been of high enough 
quality to warrant drawing conclusions about the effectiveness of pillboxes in supporting 
specific medication management and adherence behaviors. Furthermore, there is 
limited reporting in the literature of the five components of intervention fidelity with 
pillboxes, thus limiting generalizability of the study findings. Despite some articles 
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reporting that patients found the pillboxes to be useful in supporting medication taking, 
the way in which the pillbox helped to support medication-taking behaviors remains 
unknown. For example, if the pillbox helped participants to remember to take 
medications, which pillbox design features, if any, contributed to remembering, how did 
the participants use the design features to support medication-taking behaviors, and did 
the design features vary between pillboxes such that some pillboxes might be more 
effective than others? Before moving to intervention research, it is imperative to 
establish which medication-taking behaviors are supported by use of a pillbox. This 
requires understanding how people interact with their pillboxes and then developing 
theory-based interventions. These findings serve as a call to action for researchers to 
explicitly state pillbox intervention details. The lack of details provides challenges for 
clinicians, care providers and researchers to determine how pillboxes work in 
influencing medication adherence behaviors and outcomes. More high quality, well 
powered, and theory-based studies paying attention to intervention fidelity are needed 
in order to determine the effectiveness of pillboxes in supporting medication adherence. 
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